Literature DB >> 10957671

Subclavian artery disruption resulting from endovascular intervention: treatment options.

P H Lin1, R L Bush, V J Weiss, T F Dodson, E L Chaikof, A B Lumsden.   

Abstract

Endovascular intervention is a commonly accepted form of treatment in patients with subclavian artery stenosis. Complications will undoubtedly occur as the utility of catheter-based intervention continues to rise. We report two cases of subclavian artery disruption as a result of endovascular intervention. One patient had contrast extravasation after the deployment of a balloon-expandable stent in a stenotic subclavian artery, and the arterial injury was successfully treated with balloon tamponade. A second patient had a large subclavian pseudoaneurysm 4 months after a balloon-expandable stent placement. Successful repair was achieved in this patient by means of arterial reconstruction with a prosthetic bypass graft. These cases illustrate different therapeutic methods of treating subclavian artery rupture due to endovascular intervention.

Entities:  

Mesh:

Year:  2000        PMID: 10957671     DOI: 10.1067/mva.2000.109334

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  3 in total

Review 1.  Management of ruptures complicating angioplasty and stenting of supraaortic arteries: report of two cases and a review of the literature.

Authors:  L Paul Broadbent; Christopher J Moran; DeWitte T Cross; Colin P Derdeyn
Journal:  AJNR Am J Neuroradiol       Date:  2003 Nov-Dec       Impact factor: 3.825

2.  Covered stent application of a repeatedly regrowing iatrogenic subclavian artery pseudoaneurysm at the origin of the vertebral artery.

Authors:  G F Xu; D C Suh; H W Pyun; H Yoo; S W Lee; M O Huh; T Kwon; S J Kim
Journal:  Interv Neuroradiol       Date:  2007-09-13       Impact factor: 1.610

3.  [Aneurysm of the subclavian artery. An unusual cause of dysphagia].

Authors:  J P Windfuhr; D Schubert; S Remmert
Journal:  HNO       Date:  2004-12       Impact factor: 1.284

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.